4.6 Article

Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study

Journal

PLOS ONE
Volume 18, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0280871

Keywords

-

Ask authors/readers for more resources

This study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes. The results showed that hemoglobin level is associated with better survival in hemodialysis patients without diabetes, but not in those with diabetes.
BackgroundMany studies have assessed the association between anemia and mortality in hemodialysis but few compared patients with and without diabetes. Our study aims to investigate the impact of hemoglobin and iron parameters on mortality in hemodialysis patients with or without diabetes. MethodsThis is a two-center retrospective study that included all adult patients who started hemodialysis between February 2012 and February 2020, followed until January 2021. Averages of hemoglobin, ferritin and transferrin saturation of entire follow-up were recorded. Kaplan Meier survival, log rank test and cox regression analyses were performed to assess the association between anemia biomarkers and mortality. ResultsA total of 214 patients were included. Mean age was 67.98 +/- 12.41 years, mean hemoglobin was 10.92 +/- 0.75 g/dL, mean ferritin was 504.43 +/- 221.42 ng/mL and mean transferrin saturation was 26.23 +/- 7.77%. Log rank test showed an association between hemoglobin >= 11 g/dL and better survival in patients without diabetes (P = 0.028). Based on cox regression analysis, hemoglobin was associated with all-cause mortality in all patients (HR = 0.66; CI:0.49,0.89; P = 0.007). When comparing patients with and without diabetes, this association remained significant only in patients without diabetes (HR = 0.53; CI:0.37,0.77; P<0.001). Based on different multivariate models, hemoglobin, ferritin and age were independent factors associated with mortality in patients without diabetes. ConclusionsThis study showed that hemoglobin >= 11 g/dL is associated with better survival in hemodialysis patients without diabetes but not in those with diabetes. These differences need to be further explored in other countries and settings. An individualization of the hemoglobin target level might be necessary to improve patients' outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available